PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
01-Feb-2021 VasQ™ External Support Awarded NUB Status 1 Reimbursement Renewal for 2021 for 321 Hospitals Businesswire
01-Feb-2021 Adamas Announces Settlement of Patent Litigation with Zydus Businesswire
01-Feb-2021 Gilead Sciences to Increase Its Ownership In Arcus Biosciences Businesswire
01-Feb-2021 Sesen Bio Announces Successful Application Orientation Meeting (AOM) with the FDA for Vicineum™ Businesswire
01-Feb-2021 Exelixis and Adagene Enter into Collaboration and License Agreement to Develop Novel Masked Antibody-Drug Conjugate Therapies with Improved Safety and Efficacy Profiles Businesswire
01-Feb-2021 AngioDynamics Appoints Richard C. Rosenzweig Senior Vice President, General Counsel and Secretary, Promotes Juan Carlos Serna to Senior Vice President, Scientific & Clinical Affairs Businesswire
01-Feb-2021 IQVIA Named to FORTUNE’s 2021 List of “World’s Most Admired Companies” Businesswire
01-Feb-2021 Columbia Care Awarded Five Medical Dispensary Permits in West Virginia Assuring Scaled, Vertically Integrated Operations Businesswire
01-Feb-2021 Janssen Announces CAR-T Therapy Ciltacabtagene Autoleucel (Cilta-cel) Accepted for Accelerated Assessment in Europe for the Treatment of Patients with Heavily Pretreated Multiple Myeloma Businesswire
01-Feb-2021 Indication Bioscience Granted First Patent for Statin Plus Cannabidiol (CBD) Combination Businesswire
01-Feb-2021 Virios Therapeutics, Inc. Announces Research Collaboration to Explore Role of HSV-1 in Irritable Bowel Syndrome Businesswire
01-Feb-2021 Can-Fite Announces Inhibition of Liver Fibrosis by Cannabis Compounds in Preclinical Studies Businesswire
01-Feb-2021 Pinteon Therapeutics Announces Promising Phase 1 Data for Novel Tau Antibody PNT001 Businesswire
01-Feb-2021 Horizon Therapeutics plc to Acquire Viela Bio, Inc. to Significantly Expand Development Pipeline and Grow Rare Disease Medicine Portfolio Businesswire
01-Feb-2021 LENSAR Expands Board of Directors with the Appointments of Aimee S. Weisner and Elizabeth G. O’Farrell Businesswire
01-Feb-2021 Fractyl Announces Publication of Clinical Results from INSPIRE Study Showing Durable Insulin-Free Glycemic Control in Majority of Patients Treated Businesswire
01-Feb-2021 Bristol Myers Squibb Application for Zeposia® (ozanimod) for the Treatment of Ulcerative Colitis Accepted for Filing with Priority Review by U.S. Food and Drug Administration Businesswire
01-Feb-2021 Eagle Pharmaceuticals Announces Update in Vasopressin Trial; Trial Date Postponed Businesswire
01-Feb-2021 ANI Pharmaceuticals Announces Launch of Prazosin Hydrochloride (“HCl”) Capsules Businesswire
01-Feb-2021 Dr. Stephen Mayo Elected to Merck Board of Directors Businesswire